Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04371419 · ClinicalTrials.gov registry record · NA
COVID-19 Health Messaging to Underserved Communities
A NA study of Coronavirus, sponsored by National Bureau of Economic Research.
- Completed
- Registry status
- NA
- Development phase
- 14,267
- Enrollment target
- 1
- Study location
NCT04371419 is a NA study of Coronavirus that has completed, run by National Bureau of Economic Research. The registered enrollment target is 14,267 participants, above the 692-participant average among 20 other Coronavirus trials with a reported enrollment target (1962% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04371419, a NA study of Coronavirus, has completed, sponsored by National Bureau of Economic Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 14,267 participants
- Enrollment target
- 1
- Study location
Study Summary
Recent data have shown that covid19 is disproportionately infecting and killing African Americans and Latinx people in the United States. The aim of the study is to determine which messages are most effective at increasing knowledge and changing behaviors that can protect individuals and their communities from the virus. To accomplish this aim, we plan to recruit approximately 20,000 Hispanic and African-American individuals and randomly assign them to videos that vary either the sender or the framing of the message, while providing the relevant public health information.
Conditions Studied
Interventions
- BEHAVIORAL Messaging
Study Locations (1)
Massachusetts
- JPAL North America - Cambridge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14,267 participants |
| Start Date | 2020-05-13 |
| Est. Completion | 2020-05-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04371419
The ClinicalTrials.gov registry entry for NCT04371419 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14,267 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 692-participant average among 20 other Coronavirus trials with a reported enrollment target (1962% higher). The listed sponsor is National Bureau of Economic Research, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Coronavirus appearing as the primary indexed condition, and to 1 intervention - of which Messaging is the first listed.
NCT04371419 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04371419 about?
NCT04371419 is a clinical study titled "COVID-19 Health Messaging to Underserved Communities". Recent data have shown that covid19 is disproportionately infecting and killing African Americans and Latinx people in the United States. The aim of the study is to determine which messages are most effective at increasing knowledge and changing behaviors that can protect individuals and their commu...
What is the current status of trial NCT04371419?
This trial is currently completed. It is a NA study. The enrollment target is 14,267 participants. The study started on 2020-05-13. Estimated completion is 2020-05-26.
What conditions does trial NCT04371419 study?
This clinical trial studies the following conditions: Coronavirus.
What interventions are being tested in trial NCT04371419?
The interventions under investigation include: Messaging (BEHAVIORAL).
Who is sponsoring clinical trial NCT04371419?
This trial is sponsored by National Bureau of Economic Research, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04371419 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronavirus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study
RECRUITING · NA
-
Identification of a Responsive Subpopulation to Hydroxychloroquine in COVID-19 Patients Using Machine Learning
COMPLETED · NA
-
NOWDx Test for the Detection of Antibodies to COVID-19
COMPLETED · NA
-
Prospective Clinical Evaluation of the BioFire Emerging Coronavirus Panel for the Detection of COVID-19 and Other Coronaviruses
RECRUITING
-
Convalescent Plasma Collection and Treatment in Pediatrics and Adults
RECRUITING · Phase 3
-
ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.